CAPTRUST FINANCIAL ADVISORS - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,584,723
-17.9%
51,468
+3.3%
0.01%
-16.7%
Q2 2023$3,147,676
+153.7%
49,805
+80.6%
0.01%
+140.0%
Q1 2023$1,240,734
+47.0%
27,578
+43.2%
0.01%
+25.0%
Q4 2022$843,869
-24.9%
19,262
+13.0%
0.00%
-42.9%
Q3 2022$1,123,000
+30.3%
17,043
-0.2%
0.01%
+16.7%
Q2 2022$862,000
-16.7%
17,074
+5.4%
0.01%
-14.3%
Q1 2022$1,035,000
-38.9%
16,206
+2.5%
0.01%
-41.7%
Q4 2021$1,693,000
+10.9%
15,805
+6.5%
0.01%
-7.7%
Q3 2021$1,526,000
+40.6%
14,841
+20.3%
0.01%
+30.0%
Q2 2021$1,085,000
-9.6%
12,3380.0%0.01%
-23.1%
Q1 2021$1,200,000
-12.3%
12,338
+1.1%
0.01%
-27.8%
Q4 2020$1,369,000
+13.1%
12,207
-5.2%
0.02%
-10.0%
Q3 2020$1,210,000
+18.9%
12,8810.0%0.02%
+17.6%
Q2 2020$1,018,000
+58.1%
12,881
+14.2%
0.02%
+21.4%
Q1 2020$644,000
-30.1%
11,281
+0.7%
0.01%
-6.7%
Q4 2019$921,00011,2010.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders